Axel Kicillof announced on Monday that the province of Buenos Aires will begin to register for vaccination against the coronavirus “boys and girls between 13 and 17 years old with comorbidities”.
During a press conference, the president of Buenos Aires assured that his government will start with the logistical task necessary to start the vaccination process for this age group when the respective vaccines are “approved”.
“Today we have two candidate vaccines for people under 18, not yet approved. Moderna vaccine and Sinopharm vaccine. Starting today, we are opening registrations for boys and girls aged 13 to 17, especially those with co-morbidities. We open the registration to Vacunate Buenos Aires through the website or the phone app, ”he said.
Last Friday 3,500,000 doses of Moderna arrived in two Aerolineas Argentinas flights donated by the United States and which will be used to speed up the vaccination plan. These doses should be used in children and adolescents who have had previous illnesses.
In the case of Sinopharm vaccines, they are already applied in children under the age of 18 in China, but they have not been approved by the National Administration of Drugs, Food and Medical Technology (Anmat) .
“We are launching an education campaign” for girls and boys aged 13 to 17. “Registration is activated. We still don’t have qualified vaccines, “but” we do have vaccines, “said the governor of Buenos Aires.
And to add: “We are preparing to be able to design the logistics of the vaccine while we already have the approval” of the Anmat. “For us this is extremely important”.
Kicillof said the case of minors “is obviously a lower risk population”, but clarified that the goal is “start the vaccination process that leads to the vaccination of those with a disease which makes it a population at specific risk with comorbidities ”.
Vaccination of minors with comorbidities is a demand that has multiplied in recent weeks across the country. Last Saturday, a group of about 200 parents demonstrated in the Plaza de Mayo to demand the urgent vaccination of their children in risky conditions.
On this occasion, they asked for the urgent application of the Pfizer vaccine because, according to them, it is the only one authorized by the international scientific community for minors between 12 and 17 years old. However, they said if Anmat approved Moderna’s vaccine for children and adolescents, he would be welcome.